Showing results (51-60 of 100) with videos related to

Sort By:
Pageof 10
Arteriosclerosis, Thrombosis, and Vascular Biology|August 12, 2009
Association of scavenger receptors in adipose tissue with insulin resistance in nondiabetic humansNeda Rasouli, Aiwei Yao-Borengasser, Vijayalakshmi Varma, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|October 18, 2024
Design and baseline characteristics of the STRIDE trial: evaluating semaglutide in people with symptomatic peripheral artery disease and type 2 diabetesMarc P Bonaca, Andrei-Mircea Catarig, Yasemin Hansen, et al.
Journal of Lipid Research|June 27, 2006
Pioglitazone induces apoptosis of macrophages in human adipose tissueAngela M Bodles, Vijayalakshmi Varma, Aiwei Yao-Borengasser, et al.
Lancet (London, England)|April 1, 2025
Semaglutide and walking capacity in people with symptomatic peripheral artery disease and type 2 diabetes (STRIDE): a phase 3b, double-blind, randomised, placebo-controlled trialMarc P Bonaca, Andrei-Mircea Catarig, Kim Houlind, et al.
Journal of Clinical and Translational Science|February 27, 2023
Enrollment of underrepresented racial and ethnic groups in the Rare and Atypical Diabetes Network (RADIANT)Mustafa Tosur, Laura Gandolfo, Ashok Balasubramanyam, et al.
Journal of the American College of Cardiology|September 2, 2025
Sex Differences in Effectiveness of Semaglutide in Patients with Peripheral Artery Disease: The STRIDE TrialSubodh Verma, Andrei-Mircea Catarig, Kim Houlind, et al.
Diabetes Care|June 21, 2025
Benefit of Semaglutide in Symptomatic Peripheral Artery Disease by Baseline Type 2 Diabetes Characteristics: Insights From STRIDE, a Randomized, Placebo-Controlled, Double-Blind TrialNeda Rasouli, Ecenur Guder Arslan, Andrei-Mircea Catarig, et al.
Diabetes, Obesity & Metabolism|May 3, 2026
Glycaemic Control According to the Final Insulin Dose Using an Innovative Fixed-Dose Titration of Weekly Insulin Efsitora in Insulin-Naïve Type 2 DiabetesLisa Connery, Julio Rosenstock, Neda Rasouli, et al.
The Journal of Clinical Endocrinology and Metabolism|August 14, 2008
Stearoyl-coenzyme A desaturase 1 gene expression increases after pioglitazone treatment and is associated with peroxisomal proliferator-activated receptor-gamma responsivenessAiwei Yao-Borengasser, Negah Rassouli, Vijayalakshmi Varma, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|August 20, 2016
IMPACT OF GLUCOSE MANAGEMENT TEAM ON OUTCOMES OF HOSPITALIZARON IN PATIENTS WITH TYPE 2 DIABETES ADMITTED TO THE MEDICAL SERVICEYunjiao J Wang, Stacey Seggelke, R Matthew Hawkins, et al.
Pageof 10